Cargando…
Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
BACKGROUND: The mammalian cyclic guanosine monophosphate (cGMP)-dependent protein kinases type II (PKG II) plays critical physiological or pathological functions in different tissues. However, the biological effects of PKG II are dependent on cGMP. Published data indicated that L-arginine (L-Arg) pr...
Autores principales: | Wu, Yan, Liu, Ying, Cai, Zhensheng, Qin, Huijuan, Li, Hongfan, Su, Wenbin, Wang, Ying, Qian, Hai, Jiang, Lu, Wu, Min, Pang, Ji, Chen, Yongchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810367/ https://www.ncbi.nlm.nih.gov/pubmed/29401205 http://dx.doi.org/10.12659/MSM.906213 |
Ejemplares similares
-
Role of PKG II in osteoblast mechanotransduction
por: Rangaswami, Hema, et al.
Publicado: (2009) -
Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways
por: Wu, Yan, et al.
Publicado: (2019) -
PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells
por: Jiang, Lu, et al.
Publicado: (2013) -
The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades
por: Wu, Yan, et al.
Publicado: (2018) -
PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells
por: Wu, Yan, et al.
Publicado: (2016)